业务
货币单位:美元
2024/Q2
名称营收比例
U.S. Abecma collaboration with Bristol Myers Squibb’s (BMS)436.4万48.67%
ide-cel ex-U.S. service revenue from Bristol Myers Squibb’s (BMS)263.4万29.37%
Service revenue from December 2021 agreement with Novo Nordisk198.7万22.16%
Collaboration with Regeneron-1.8万-0.20%
地区
货币单位:美元
2023/FY
名称营收比例
美国1亿100.00%
